In addition, there are homologous sequences between the S protein of SARS-CoV-2 and the fusion protein F1 of measles virus and the envelope protein E1 of rubella, and they seem to have epitope properties (118), which suggests that receiving measles-rubella vaccine may also develop an immune response to SARS-CoV-2 infection. This evidence concerns the gene PROS1 and rubella.